Mizuho Securities USA’s iShares Biotechnology ETF IBB Stock Holding History

Mizuho Securities USA’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-34,000	Closed	-$5.57M	–	263
2021 Q2	$5.57M	Buy	34,000 +7,000	+26%	+$1.08M	0.45%	34
2021 Q1	$4.06M	Sell	27,000 -13,000	-33%	-$2.06M	0.39%	57
2020 Q4	$6.06M	Buy	40,000 +31,000	+344%	+$4.43M	0.36%	25
2020 Q3	$1.22M	Sell	9,000 -32,000	-78%	-$4.34M	0.09%	98
2020 Q2	$5.61M	Buy	+41,000	New	+$5.23M	0.38%	36

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Mizuho Securities USA's IBB Position: Q3 2021 in Review

Mizuho Securities USA sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 34,000 shares — an estimated $5.57M sold.

Mizuho Securities USA first reported a position in IBB in Q2 2020 and held it in 5 quarters. The position peaked at $6.06M in Q4 2020. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Mizuho Securities USA reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
Mizuho Securities USA sold 34,000 iShares Biotechnology ETF shares in Q3 2021, an estimated $5.57M.
Mizuho Securities USA first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 5 quarters.
Mizuho Securities USA's iShares Biotechnology ETF position peaked at $6.06M in Q4 2020.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Mizuho Securities USA's 13F filing for Q3 2021, filed 28 Oct 2021.